NovoCure Competitors and Similar CompaniesClear all
NovoCure's competitors and similar companies include Lyell, Silverback Therapeutics, Sensei Biotherapeutics, Accuray, Zymeworks and Legend Biotech.
 NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Silverback Therapeutics Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases. |  Sensei Biotherapeutics Sensei Biotherapeutics (formerly known as Panacea Pharmaceuticals) is a biotechnology company developing biologics therapies targeting key components of the immune system for the treatment of cancers. |  Accuray Accuray is a radiation oncology company that develops, manufactures, sells, and supports precise tumor treatment solutions. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
| ||
Founding Date | Founding Date 2000 | Founding Date 2018 | Founding Date 2016 | Founding Date 1999 | Founding Date 1990 | Founding Date 2003 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Seattle, US HQ | Locations Boston, US HQ Boston, US Rockville, US | Locations Sunnyvale, US HQ Chengdu, CN Hong Kong, HK Tokyo, JP Morges, CH Madison, US | Locations Vancouver, CA HQ Seattle, US | Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US | |
Employees | Employees 1,453 | Employees 188 | Employees 9067% increase | Employees 2812% increase | Employees 1,0242% decrease | Employees 45519% increase | Employees 1,80029% increase |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 243.3 m | Valuation ($) 550.4 m | Valuation ($) 14.8 m | Valuation ($) 186.5 m | Valuation ($) 973.3 m | Valuation ($) 8.4 b |
Financial | |||||||
Revenue (est.) | Revenue (est.) $509.3m (FY, 2023) | Revenue (est.) $130k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $446.6m (FY, 2024) | Revenue (est.) $76m (FY, 2023) | Revenue (est.) $285.1m (FY, 2023) |
Cost of goods | Cost of goods $128.3m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $303.6m (FY, 2024) | Cost of goods N/A | Cost of goods $144.2m (FY, 2023) |
Gross profit | Gross profit $381.1m (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $142.9m (FY, 2024) | Gross profit N/A | Gross profit $140.9m (FY, 2023) |
Net income | Net income ($207m) (FY, 2023) | Net income ($234.6m) (FY, 2023) | Net income ($89.5m) (FY, 2021) | Net income ($34.1m) (FY, 2023) | Net income ($15.5m) (FY, 2024) | Net income ($118.7m) (FY, 2023) | Net income ($518.3m) (FY, 2023) |
Funding | |||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 211m | Total funding raised $ 28.5m | Total funding raised N/A | Total funding raised $ 125.9m | Total funding raised $ 150.5m |
For sources of this data, please see the company profile
View Company Profiles
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View companySilverback Therapeutics
HQ
Seattle, US
Employees
90
Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
View companySensei Biotherapeutics
HQ
Boston, US
Employees
28↑ 12% increase
Sensei Biotherapeutics (formerly known as Panacea Pharmaceuticals) is a biotechnology company developing biologics therapies targeting key components of the immune system for the treatment of cancers.
View companyAccuray
HQ
Sunnyvale, US
Employees
1,024↓ 2% decrease
Accuray is a radiation oncology company that develops, manufactures, sells, and supports precise tumor treatment solutions.
View company